Results
338
Companies with a Future performance score of at least 3, ordered by Future performance score.
338 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
INIT | SEK 7.10 | 0% | -11.3% | SEK 398.6m | SEK 22.50 | PB16.8x | E31.7% | n/a | Pharmaceuticals & Biotech | ||
JOBS | SEK 19.50 | -2.0% | -23.8% | SEK 96.9m | SEK 39.00 | PE11.8x | E44.8% | 8.5% | Commercial Services | ||
DIGN | SEK 1.05 | -5.4% | -44.7% | SEK 84.6m | SEK 5.50 | PS1x | E118.7% | n/a | Healthcare | ||
ENRAD | SEK 11.70 | -12.0% | 156.6% | SEK 285.6m | SEK 8.90 | PE72.8x | E50.9% | n/a | Capital Goods | ||
CAMX | SEK 594.00 | -1.0% | 35.2% | SEK 34.8b | SEK 757.67 | PE81.3x | E50.4% | n/a | Pharmaceuticals & Biotech | ||
ENGCON B | SEK 111.40 | 4.1% | 28.4% | SEK 16.9b | SEK 107.50 | PE97.7x | E41.8% | 0.8% | Capital Goods | ||
YUBICO | SEK 218.00 | -14.2% | 5.3% | SEK 18.8b | SEK 315.00 | PE50.6x | E27.2% | n/a | Software | ||
MIPS | SEK 514.00 | -4.2% | 48.6% | SEK 13.6b | SEK 630.00 | PE96.6x | E35.9% | 1.3% | Consumer Durables | ||
MILDEF | SEK 148.80 | -4.7% | 116.9% | SEK 6.8b | SEK 142.50 | PS5.6x | E74.2% | 0.3% | Capital Goods | ||
DVYSR | SEK 137.00 | 2.6% | 73.0% | SEK 2.3b | SEK 164.98 | PS10.5x | E96.7% | n/a | Pharmaceuticals & Biotech | ||
KLAR | SEK 1.58 | 30.6% | 243.5% | SEK 228.7m | SEK 1.20 | PB17.7x | E93.9% | n/a | Pharmaceuticals & Biotech | ||
BONEX | SEK 329.60 | -7.8% | 85.7% | SEK 21.7b | SEK 422.33 | PE239.5x | E73.1% | n/a | Pharmaceuticals & Biotech | ||
TRUE B | SEK 68.75 | 0.3% | 119.9% | SEK 23.6b | SEK 72.57 | PE48.1x | E26.6% | 0.6% | Software | ||
XBRANE | SEK 0.16 | -11.0% | -92.8% | SEK 248.2m | SEK 0.45 | PS1.2x | E128.5% | n/a | Pharmaceuticals & Biotech | ||
SKOLON | SEK 32.10 | -4.5% | 29.4% | SEK 852.1m | SEK 37.50 | PS5.6x | E131.5% | 1.7% | Software | ||
EGTX | SEK 5.80 | -4.6% | 11.5% | SEK 2.1b | SEK 11.40 | PS30.7x | E97.3% | n/a | Pharmaceuticals & Biotech | ||
BIOA B | SEK 212.40 | -5.1% | -5.0% | SEK 18.8b | SEK 333.20 | PS73x | E44.6% | 0% | Pharmaceuticals & Biotech | ||
PAX | SEK 66.20 | -6.0% | 70.2% | SEK 1.3b | SEK 80.00 | PE47.9x | E60.8% | n/a | Healthcare | ||
CRAD B | SEK 32.10 | 2.2% | -32.1% | SEK 1.1b | SEK 48.00 | PE19.1x | E26.5% | n/a | Healthcare | ||
OSSD | SEK 12.36 | -1.9% | 37.3% | SEK 1.2b | SEK 13.00 | PS9x | E68.9% | n/a | Healthcare | ||
SHOT | SEK 80.50 | 0.4% | 69.8% | SEK 17.5b | SEK 69.03 | PE32.3x | E23.9% | 0% | Consumer Services | ||
CEVI | SEK 196.00 | -2.5% | -27.0% | SEK 4.7b | SEK 242.50 | PE33.2x | E20.7% | 1.3% | Healthcare | ||
SECT B | SEK 256.95 | 1.9% | 18.3% | SEK 49.5b | SEK 285.00 | PE128.8x | E27.9% | 0.4% | Healthcare | ||
KEBNI B | SEK 1.09 | 9.8% | -24.3% | SEK 295.6m | SEK 1.35 | PE147.7x | E54.3% | n/a | Tech |